There is also evidence that AMP-activated protein kinase (AMPK), an important coordinator of metabolic pathways in response to energetic fluctuations [22], is activated by FK866 in prostate cancer cells affecting lipogenesis [23] and in hepatocarcinoma cells with impact on MTOR/4EBP1 signaling [24]. Here, PRKAA2 is linked to Familial prostate cancer.